How many drugs treat Contraception?

Drug Landscape tracks 10 marketed treatments for Contraception (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

What's the most recent regulatory action in Contraception?

Most recent: Estring — FDA approved.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/contraception.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Contraception — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Contraception (disease) competitive landscape: 10 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

10 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Contraception, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Slynd	DROSPIRENONE	Exeltis Usa Inc	Progestin	Mineralocorticoid receptor	2019-01-01
Natazia	DIENOGEST	Mochida Pharmaceutical Co., Ltd.	Progestin	Progesterone receptor	2010-01-01
Ortho-Cept	DESOGESTREL	Merck & Co.	Progestin	Sex hormone-binding globulin	1992-01-01
Iron Fumarate	FERROUS FUMARATE	Pfizer	Vitamin C [EPC]		1986-01-01
Cyklokapron	TRANEXAMIC ACID	Exela Pharma	Antifibrinolytic Agent [EPC]	Plasminogen	1986-01-01
Depoestradiol	ESTRADIOL CYPIONATE	Pfizer	Estrogen	Estrogen receptor beta	1979-01-01
Estron	ESTRONE	Watson Labs	estrone	Estrogen receptor	1979-01-01
Estrace	ESTRADIOL	Pfizer	Estrogen	Estrogen receptor	1975-01-01
Aygestin	NORETHINDRONE ACETATE	Duramed Res	Estrogen [EPC]	Progesterone receptor	1973-01-01
Jadelle	LEVONORGESTREL	Fdn Consumer	Progestin	Progesterone receptor	1968-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

2026-05-11 — Estring · FDA · approved · US

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 5 drugs in Contraception
Pfizer · 5 drugs in Contraception
Merck & Co. · 2 drugs in Contraception
Exela Pharma · 1 drug in Contraception
Exeltis Usa Inc · 1 drug in Contraception
Fdn Consumer · 1 drug in Contraception
Ferring · 1 drug in Contraception
Fundación Pública Andaluza Progreso y Salud · 1 drug in Contraception
Johnson & Johnson · 1 drug in Contraception
Erzincan Military Hospital · 1 drug in Contraception
Minia University · 1 drug in Contraception
Mochida Pharmaceutical Co., Ltd. · 1 drug in Contraception

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Contraception:

Cite this brief

Drug Landscape (2026). Contraception — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/contraception. Accessed 2026-06-10.

Contraception full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing